Soleno Therapeutics, Inc. Profile Avatar - Palmy Investing

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily ora…

Biotechnology
US, Redwood City [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Soleno Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Soleno Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Soleno Therapeutics, Inc..

End of SLNO's Analysis
CIK: 1484565 CUSIP: 834203200 ISIN: US8342033094 LEI: - UEI: -
Secondary Listings
SLNO has no secondary listings inside our databases.